secwatch.observer — SEC 8-K summary
======================================

Issuer:     Trevi Therapeutics, Inc. (TRVI)
CIK:        0001563880
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0000950170-25-087486
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Trevi shareholders approve 6M share increase for 2019 Stock Incentive Plan
--------------------------------------------------------------------------

- Stockholders voted to increase authorized shares under the 2019 Plan by 6,000,000 shares.
- Class III directors Jennifer Good and Anne VanLent re-elected with 78.8M and 62.9M votes for, respectively.
- Ratification of Ernst & Young as auditor for FY2025 passed with 88.9M votes for.
- Advisory say-on-pay approved (78.3M for, 0.7M against); future votes will be held every year.
- All proposals, including the equity plan amendment, received required majority approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563880/000095017025087486/0000950170-25-087486-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563880/000095017025087486/trvi-20250611.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-087486

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer